Bolt Biotherapeutics, Inc. (BOLT) › Shareholders' EquityBolt Biotherapeutics, Inc. (BOLT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$45.85M2020: -$104.95M2021: $250.12M2022: $171.51M2023: $112.74M2024: $57.20M2025: $26.50M$26.50M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$26.50M-53.7%2024$57.20M-49.3%2023$112.74M-34.3%2022$171.51M-31.4%2021$250.12M+338.3%2020-$104.95M-128.9%2019-$45.85M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share